Clinical Trial Detail

NCT ID NCT02337686
Title Pharmacodynamic Study of Pembrolizumab in Patients With Recurrent Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

malignant glioma

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.